At close: December 23 at 8:08:23 AM GMT+1
Key Executives
Key Executives Information Not Available
Lineage Cell Therapeutics Inc
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Lineage Cell Therapeutics Inc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 5, 2025 at 10:59 AM UTC - March 10, 2025 at 12:00 PM UTC
Lineage Cell Therapeutics Inc Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
HPHA.BE Heidelberg Pharma AG
2.2600
0.00%
52U.F Hyloris Pharmaceuticals SA
5.18
-1.15%
BT1.F BioSenic S.A.
0.0123
0.00%
PHG.F Pharming Group N.V.
8.60
+2.99%
OVIT OncoVista Innovative Therapies, Inc.
0.0002
0.00%
HSTC HST Global, Inc.
0.8300
0.00%
PHGN.BE Pharming Group
0.8715
+2.77%
8BT.F BriaCell Therapeutics Corp.
0.4600
-6.12%
028300.KQ HLB Co., Ltd.
66,600.00
-0.15%
CZTA.BE Checkpoint Therapeutics Inc
3.3950
-3.00%